These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias. Parratt JR; Coker SJ J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S65-70. PubMed ID: 2410739 [TBL] [Abstract][Full Text] [Related]
5. Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation? Parratt JR Eur Heart J; 1986 Jul; 7 Suppl B():19-25. PubMed ID: 2875873 [TBL] [Abstract][Full Text] [Related]
6. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion. Parratt JR; Coker SJ; Wainwright CL J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of myocardial ischaemia and the prevention of necrosis. Taylor RR Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288 [No Abstract] [Full Text] [Related]
9. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction. Yusuf S Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466 [No Abstract] [Full Text] [Related]
10. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion? Ehring T; Heusch G Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166 [TBL] [Abstract][Full Text] [Related]
11. The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9. Curtis MJ; Walker MJ Br J Pharmacol; 1988 Aug; 94(4):1275-86. PubMed ID: 3207985 [TBL] [Abstract][Full Text] [Related]
13. The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Daugherty A; Frayn KN; Redfern WS; Woodward B Br J Pharmacol; 1986 Jan; 87(1):265-77. PubMed ID: 2869812 [TBL] [Abstract][Full Text] [Related]
14. Combined receptor intervention and myocardial infarction. Chamberlain DA; Vincent R Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893 [TBL] [Abstract][Full Text] [Related]
15. [Secondary prevention in the post-infarction period]. Corea L; Bentivoglio M Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624 [No Abstract] [Full Text] [Related]
16. Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established. Hugenholtz PG; Serruys PW; Fleckenstein A; Nayler W Eur Heart J; 1986 Apr; 7(4):270-8. PubMed ID: 2873037 [No Abstract] [Full Text] [Related]
17. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization. Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812 [TBL] [Abstract][Full Text] [Related]
18. [Drugs blocking the calcium channel]. Dabrowski M Kardiol Pol; 1982; 25(1):75-87. PubMed ID: 6285064 [No Abstract] [Full Text] [Related]